228 related articles for article (PubMed ID: 32291326)
1. Complement-Dependent Synaptic Uptake and Cognitive Decline after Stroke and Reperfusion Therapy.
Alawieh AM; Langley EF; Feng W; Spiotta AM; Tomlinson S
J Neurosci; 2020 May; 40(20):4042-4058. PubMed ID: 32291326
[TBL] [Abstract][Full Text] [Related]
2. Acute Complement Inhibition Potentiates Neurorehabilitation and Enhances tPA-Mediated Neuroprotection.
Alawieh A; Andersen M; Adkins DL; Tomlinson S
J Neurosci; 2018 Jul; 38(29):6527-6545. PubMed ID: 29921716
[TBL] [Abstract][Full Text] [Related]
3. Targeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice.
Alawieh A; Langley EF; Tomlinson S
Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769288
[TBL] [Abstract][Full Text] [Related]
4. Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke.
Hoda MN; Siddiqui S; Herberg S; Periyasamy-Thandavan S; Bhatia K; Hafez SS; Johnson MH; Hill WD; Ergul A; Fagan SC; Hess DC
Stroke; 2012 Oct; 43(10):2794-9. PubMed ID: 22910893
[TBL] [Abstract][Full Text] [Related]
5. Complement Drives Synaptic Degeneration and Progressive Cognitive Decline in the Chronic Phase after Traumatic Brain Injury.
Alawieh A; Chalhoub RM; Mallah K; Langley EF; York M; Broome H; Couch C; Adkins D; Tomlinson S
J Neurosci; 2021 Feb; 41(8):1830-1843. PubMed ID: 33446516
[TBL] [Abstract][Full Text] [Related]
6. Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance.
Liu DL; Hong Z; Li JY; Yang YX; Chen C; Du JR
J Neuroinflammation; 2021 Jun; 18(1):143. PubMed ID: 34162400
[TBL] [Abstract][Full Text] [Related]
7. Complement mediates neuroinflammation and cognitive decline at extended chronic time points after traumatic brain injury.
Mallah K; Couch C; Alshareef M; Borucki D; Yang X; Alawieh A; Tomlinson S
Acta Neuropathol Commun; 2021 Apr; 9(1):72. PubMed ID: 33879257
[TBL] [Abstract][Full Text] [Related]
8. Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke.
Cheng G; Zhao W; Xin Y; Huang G; Liu Y; Li Z; Zhan M; Li Y; Lu L; van Leyen K; Liu Y
J Neurochem; 2021 May; 157(3):586-598. PubMed ID: 33481248
[TBL] [Abstract][Full Text] [Related]
9. Identifying the Role of Complement in Triggering Neuroinflammation after Traumatic Brain Injury.
Alawieh A; Langley EF; Weber S; Adkins D; Tomlinson S
J Neurosci; 2018 Mar; 38(10):2519-2532. PubMed ID: 29437855
[TBL] [Abstract][Full Text] [Related]
10. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
[TBL] [Abstract][Full Text] [Related]
11. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
[TBL] [Abstract][Full Text] [Related]
12. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment - Synergistic effect of thrombolysis and antioxidant.
Mei T; Kim A; Vong LB; Marushima A; Puentes S; Matsumaru Y; Matsumura A; Nagasaki Y
Biomaterials; 2019 Sep; 215():119209. PubMed ID: 31181394
[TBL] [Abstract][Full Text] [Related]
13. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
[TBL] [Abstract][Full Text] [Related]
14. Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice.
El Amki M; Lerouet D; Garraud M; Teng F; Beray-Berthat V; Coqueran B; Barsacq B; Abbou C; Palmier B; Marchand-Leroux C; Margaill I
Mol Neurobiol; 2018 Dec; 55(12):9156-9168. PubMed ID: 29651748
[TBL] [Abstract][Full Text] [Related]
15. Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes.
Picanço MR; Christensen S; Campbell BC; Churilov L; Parsons MW; Desmond PM; Barber PA; Levi CR; Bladin CF; Donnan GA; Davis SM;
Int J Stroke; 2014 Apr; 9(3):266-9. PubMed ID: 24256139
[TBL] [Abstract][Full Text] [Related]
16. Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement.
Alawieh A; Elvington A; Zhu H; Yu J; Kindy MS; Atkinson C; Tomlinson S
J Neuroinflammation; 2015 Dec; 12():247. PubMed ID: 26714866
[TBL] [Abstract][Full Text] [Related]
17. Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model.
Esmaeeli-Nadimi A; Kennedy D; Allahtavakoli M
Eur J Pharmacol; 2015 Oct; 764():55-62. PubMed ID: 26123846
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study.
Kollmar R; Henninger N; Bardutzky J; Schellinger PD; Schäbitz WR; Schwab S
Exp Neurol; 2004 Nov; 190(1):204-12. PubMed ID: 15473993
[TBL] [Abstract][Full Text] [Related]
19. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats.
Tan Z; Li X; Turner RC; Logsdon AF; Lucke-Wold B; DiPasquale K; Jeong SS; Chen R; Huber JD; Rosen CL
Eur J Pharmacol; 2014 Sep; 738():368-73. PubMed ID: 24933645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
